Brain scan provides vital tool to improve clinical trials
Researchers and drug companies have a new tool in the search for better treatments for Parkinson's - a brain scan that can be used to select the right people for clinical trials.
Research shows targeting LRRK2 could benefit many with Parkinson's
New research highlights importance of LRRK2 as a pivotal player in all kinds of Parkinson's, not just genetic forms.
Diabetes-type drug may slow Parkinson's
Researchers in America have developed an experimental drug, similar to compounds used to treat diabetes, that slows the progression of Parkinson's in a mouse model of the condition.
Study finds potential benefits of vitamin B3
Researchers have discovered that nicotinamide riboside, a form of vitamin B3, may boost energy in nerve cells and help prevent them being lost in Parkinson's.
Exenatide found to have positive effect on mood
Further analysis of the results from a recent clinical trial of the type 2 diabetes drug exenatide in people with Parkinson's has revealed encouraging signs of a positive effect on mood.
UK-wide trial to test treatment for balance, walking and falls
The trial will test whether drug treatment with a commonly prescribed dementia drug can improve balance and walking and help to prevent falls in people with Parkinson's.
Promising results from first year of NTCELL trial
The latest update, one year into a clinical trial happening in Australia and New Zealand, show promising results for the safety and effectiveness of NTCELL® therapy.
Anticholinergic drugs may increase risk of dementia
New research has suggested a link between taking anticholinergic medications and an increased risk of developing dementia. These drugs are old and are now rarely used for Parkinson’s.
Using patient data to plan better services and find a cure
Importance of using patent data to plan health and care services and find better treatments and introducing the new national data opt-out for England from 25 May, where patients can opt-out of having their confidential info shared with the NHS.
Artificial intelligence to help develop new Parkinson’s treatments
We are pleased to announce that a Parkinson's research project has been awarded the inaugural BenevolentAI Award. The project will use an artificial intelligence platform’s capabilities to reason, deduce and suggest entirely new treatments for Parkinson’s.